Dehaier Medical Systems Ltd. (Nasdaq: DHRM), an emerging leader in the development, assembly, marketing and sale of medical devices and homecare medical products in China, today reaffirmed the company's earlier earnings estimate of $0.80 EPS for fiscal year 2010.
At a bell ringing ceremony at Nasdaq, CEO Ping Chen said, "In our S-1 filing, when we went public, we set a target for our company to earn $0.80 per share in 2010. Based on the current tone of business and our preliminary unaudited results from the second quarter, which ended last week, we remain confident in this projection. Due to the nature of our business and its seasonality, the majority of revenues are received in the third and fourth quarters."
The remarks were made as Mr. Chen rang the closing bell at Nasdaq and began a week-long series of meetings with investors and members of the financial community in New York.
Mr. Chen said, "Our business has grown through innovation and the development of our own medical device products as well as selling, distributing and servicing medical products of foreign companies including several American companies. China's medical industry is on the edge of profound change and rapid growth through the increasing introduction of modern medical technology to supplement China's historic reliance on traditional medicine. Our company is already a leader in respiratory and oxygen home care equipment in China and in the years ahead we intend to expand our product line and grow our business in China as well as abroad."
Majority of AI clinical trials report positive outcomes, yet concerns over generalizability persist